These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38307729)

  • 21. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 22. Interventions for neurocognitive deficits: editor's introduction.
    Green MF
    Schizophr Bull; 1999; 25(2):197-200. PubMed ID: 10416726
    [No Abstract]   [Full Text] [Related]  

  • 23. Studying the effectiveness of neurocognitive remediation in schizophrenia.
    Jaeger J
    Schizophr Bull; 1999; 25(2):193-6. PubMed ID: 10416725
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurocognitive correlates of type 1 diabetes mellitus in childhood.
    Desrocher M; Rovet J
    Child Neuropsychol; 2004 Mar; 10(1):36-52. PubMed ID: 14977514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.
    McClintock SM; Minto L; Denney DA; Bailey KC; Cullum CM; Dotson VM
    Curr Psychiatry Rep; 2021 Jul; 23(9):55. PubMed ID: 34255167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy.
    Eack SM; Bahorik AL; Hogarty SS; Greenwald DP; Litschge MY; Mazefsky CA; Minshew NJ
    J Autism Dev Disord; 2013 Sep; 43(9):2233-7. PubMed ID: 23381484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered neurocognitive functions in a patient with carbon monoxide poisoning.
    Arreguín-González IJ; Ayala-Guerrero F; Gasca-Zamudio PD; Melo-Balderas MA
    Neurologia; 2016; 31(6):416-7. PubMed ID: 25553934
    [No Abstract]   [Full Text] [Related]  

  • 29. Testing covariates of Type 2 diabetes-cognition associations in older adults: moderating or mediating effects?
    McFall GP; Geall BP; Fischer AL; Dolcos S; Dixon RA
    Neuropsychology; 2010 Sep; 24(5):547-562. PubMed ID: 20804243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a specific order of appearance of financial capacity deficits across neurocognitive disorders? What comes first and what should be treated.
    Giannouli V; Tsolaki M
    Int J Geriatr Psychiatry; 2023 Feb; 38(2):e5880. PubMed ID: 36710426
    [No Abstract]   [Full Text] [Related]  

  • 31. Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?
    Sheppard DP; Woods SP; Bondi MW; Gilbert PE; Massman PJ; Doyle KL;
    Clin Neuropsychol; 2015; 29(5):656-77. PubMed ID: 26367342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.
    Kabuba N; Anitha Menon J; Franklin DR; Heaton RK; Hestad KA
    AIDS Behav; 2017 Jun; 21(6):1717-1727. PubMed ID: 27278547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive effects of HIV, hepatitis C, and substance use history.
    Devlin KN; Gongvatana A; Clark US; Chasman JD; Westbrook ML; Tashima KT; Navia B; Cohen RA
    J Int Neuropsychol Soc; 2012 Jan; 18(1):68-78. PubMed ID: 22132928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive functioning over 3 years in community dwelling older adults with chronic partial epilepsy.
    Griffith HR; Martin RC; Bambara JK; Faught E; Vogtle LK; Marson DC
    Epilepsy Res; 2007 May; 74(2-3):91-6. PubMed ID: 17368001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major and minor neurocognitive disorders in DSM-5: the difference between the map and the terrain.
    Looi JC; Velakoulis D
    Aust N Z J Psychiatry; 2014 Mar; 48(3):284-6. PubMed ID: 24293049
    [No Abstract]   [Full Text] [Related]  

  • 36. Cognitive impairment in Wilson's disease.
    Medalia A
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):349-50. PubMed ID: 1498590
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurocognitive growth charts and psychosis: is the relationship predictive?
    Cannon TD
    JAMA Psychiatry; 2014 Apr; 71(4):361-2. PubMed ID: 24499862
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.
    McClintock SM; Husain MM; Greer TL; Cullum CM
    Neuropsychology; 2010 Jan; 24(1):9-34. PubMed ID: 20063944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emotional and cognitive correlates of multiple sclerosis.
    White RF
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):422-8. PubMed ID: 2136396
    [No Abstract]   [Full Text] [Related]  

  • 40. Severity of neuropsychological dysfunction rather than etiology determines the severity of interictal behavior disorder.
    Verma NP; Nichols CD
    Seizure; 1993 Jun; 2(2):105-9. PubMed ID: 8167960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.